Proteomics and peptidomics: moving toward precision medicine in urological malignancies

Urological malignancies are a major cause of morbidity and mortality worldwide. Advances in early detection, diagnosis, prognosis and prediction of treatment response can significantly improve patient care. Proteomic and peptidomic profiling studies are at the centre of kidney, prostate and bladder...

Descripción completa

Detalles Bibliográficos
Autores principales: Meo, Ashley Di, Pasic, Maria D., Yousef, George M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239567/
https://www.ncbi.nlm.nih.gov/pubmed/27119500
http://dx.doi.org/10.18632/oncotarget.8931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239567/
https://www.ncbi.nlm.nih.gov/pubmed/27119500
http://dx.doi.org/10.18632/oncotarget.8931

Ejemplares similares